XML 60 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Geographic and Product Data
 9 Months Ended
Sep. 27, 2013
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
Note 9 — Geographic and Product Data
 
The Company markets and sells its products in over 60 countries and has manufacturing sites in the United States and Switzerland. Other than the United States, Japan, Korea, China, and Spain, the Company does not conduct business in any country in which its sales exceed 5% of consolidated sales. Sales are attributed to countries based on location of customers. The composition of the Company’s net sales to unaffiliated customers is set forth below (in thousands):
 
 
 
Three Months Ended
 
Nine Months Ended
 
 
 
 
September 27,
 
 
September 28,
 
 
September 27,
 
 
September 28,
 
 
 
 
2013
 
 
2012
 
 
2013
 
 
2012
 
United States
 
$
2,993
 
$
3,038
 
$
9,388
 
$
9,428
 
Japan
 
 
4,040
 
 
4,237
 
 
13,427
 
 
12,187
 
China
 
 
2,275
 
 
2,444
 
 
6,575
 
 
6,691
 
Korea
 
 
1,982
 
 
1,755
 
 
5,851
 
 
5,379
 
Spain
 
 
1,012
 
 
808
 
 
3,466
 
 
1,850
 
Other
 
 
4,804
 
 
3,584
 
 
14,564
 
 
11,781
 
Total
 
$
17,106
 
$
15,866
 
$
53,271
 
$
47,316
 
 
100% of the Company’s sales are generated from the ophthalmic surgical product segment and therefore the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are implantable Collamer lenses (“ICLs”) used in refractive surgery and intraocular lenses (“IOLs”) used in cataract surgery. The composition of the Company’s net sales by product line is as follows (in thousands):
 
 
 
Three Months Ended
 
Nine Months Ended
 
 
 
September 27,
 
September 28,
 
September 27,
 
September 28,
 
 
 
2013
 
2012
 
2013
 
2012
 
ICLs
 
$
10,725
 
$
9,111
 
$
32,616
 
$
26,321
 
IOLs
 
 
5,322
 
 
6,052
 
 
17,533
 
 
19,185
 
Core products
 
 
16,047
 
 
15,163
 
 
50,149
 
 
45,506
 
Other Surgical Products
 
 
1,059
 
 
703
 
 
3,122
 
 
1,810
 
Total
 
$
17,106
 
$
15,866
 
$
53,271
 
$
47,316
 
 
The Company sells its products internationally, which subjects the Company to several potential risks, regional/country economic conditions and regulatory requirements, including fluctuating foreign currency exchange rates (to the extent the Company’s transactions are not in U.S. dollars), regulation of fund transfers by foreign governments, United States and foreign export and import duties and tariffs, and political instability.